Effect on the Atherogenic Marker Plasminogen Activator Inhibitor Type-1 of Addition of the ACE Inhibitor Imidapril to Angiotensin II Type 1 Receptor Antagonist Therapy in Hypertensive Patients with Abnormal Glucose Metabolism: A Prospective Cohort Study in Primary Care

Author: Yajima Ken   Shimada Akira  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.29, Iss.12, 2009-12, pp. : 811-819

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract